PetVivo Q2 FY2024 net loss widens to $3.66M; revenue down to $207K

PetVivo Holdings, Inc.

2024-Q2 EPS reported -$0.53 revenue$324,549

Revenue $207,366 vs $223,280 YoY, driven by lower clinic sales ($63,760 vs $105,016).
Net loss $3.66M ($0.28 EPS) vs $2.11M ($0.21 EPS) YoY; operating loss $2.94M.
Raised $2.35M from convertible note and registered direct offering in Q2.
Entered ATM sales agreement for up to $2.5M; raised additional $870K post-quarter.
Cash $55K at Sept 30, 2023; working capital $100K; clinical trial data for Spryng released.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PetVivo Holdings, Inc. reported three months ended September 30, 2023 results: revenue $207,366, net income $3,661,153, EPS ($0.28) per share.

Period: three months ended September 30, 2023
Revenue: $207,366
Net income: $3,661,153
EPS: ($0.28) per share
Result: reported results

Exact text from the filing

Second Quarter Financial Results For The Three Months Ended September 30, 2023 Compared to The Three Months Ended September 30, 2022 Total Revenues . Revenues were $207,366 and $223,280 for three months ended September 30, 2023 and 2022, respectively. Revenues in the three months ended September 30, 2023 consist of sales of our SpryngTM product to

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PetVivo Holdings, Inc. reported six months ended September 30, 2023 results: revenue $324,549, net income $6,554,730, EPS ($0.53) per share.

Period: six months ended September 30, 2023
Revenue: $324,549
Net income: $6,554,730
EPS: ($0.53) per share
Result: reported results

Exact text from the filing

of shares outstanding was 12,987,641 and 10,053,463 for the three months ended September 30, 2023 and 2022, respectively. Year to Date Financial Results Revenues . Revenues were $324,549 for six the months ended September 30, 2023 compared to revenues of $281,454 in the six months ended September 30, 2022. Revenues in the six months ended September 30, 2023

View on SEC.gov

Browse all earnings releases →

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-040985

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.